TickerFacts.

Advanced Biomed Inc. (ADVB): Capital Expenditures

Annual figures by period end, from SEC filings.

$31.6K
Year ended 2025-06-30
$36.1K
Trailing 12 months to 2026-03-31
$74.1K2024-06-30: $74.1K2025-06-30: $31.6K$31.6K
2024-06-30 Capital Expenditures (USD) 2025-06-30
Period endedCapital ExpendituresChange YoYSource filing
2025-06-30$31.6K-57.3%2025-10-08, From 2024-07-01
2024-06-30$74.1Kn/a2025-10-08, From 2023-07-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Advanced Biomed Inc. (ADVB)2025-06-30$31.6K-57.3%
BioNexus Gene Lab Corp (BGLC)2025-12-31$37.0K-83.7%
Aclarion, Inc. (ACON)2025-12-31$21.5K+320.9%
YD Bio Ltd (YDES)2025-12-31$1.44Mn/m
American Shared Hospital Services (AMS)2025-12-31$7.63M-3.8%
Exagen Inc. (XGN)2025-12-31$641.0K+24.5%
Biodesix Inc (BDSX)2025-12-31$259.0K-92.0%
Sera Prognostics, Inc. (SERA)2025-12-31$726.0Kn/m
Personalis, Inc. (PSNL)2025-12-31$4.50M+181.0%

Compare ADVB, BGLC, ACON, YDES side by side · Screen every company in Services-Medical Laboratories ↗